Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [ACTIVE] · [BUSINESS]

2 clusters · 5 sources · 8 days · First seen 10 days ago · Last updated 2 days ago

Veeva Systems life sciences technology expansion

Overview

Veeva Systems has expanded its life sciences technology suite through new pharmaceutical partnerships and product launches. Companies including Biogen and Regeneron Pharmaceuticals have selected Veeva Vault CRM to modernize commercial operations, with Regeneron specifically aiming to use artificial intelligence to analyze interactions between field personnel and healthcare providers.

Veeva also introduced Veeva Falcon Safety, an agentic AI product intended to automate pharmacovigilance tasks such as adverse event intake and case processing.

Following these developments, Veeva Systems and AbbVie Inc. presented at the Wells Fargo 21st Annual Healthcare Conference. Veeva provided an overview of its industry cloud for life sciences, detailing software, data products, and agents designed to improve efficiency across clinical, regulatory, safety, and commercial sectors.

Entities

AbbVie Inc. · Wells Fargo · Regeneron Pharmaceuticals · Veeva Systems Inc. · BridgeBio Pharma, Inc.

Timeline

2 days ago

[BUSINESS] 3 sources
Healthcare sector analysis: AbbVie, Novo Nordisk, and BridgeBio Pharma
Major pharmaceutical and biotech firms AbbVie, Novo Nordisk, and BridgeBio Pharma report diverse growth strategies and significant sales potential in immunology, metabolic health, and chronic care.
10 days ago

[BUSINESS] 2 sources
Veeva Systems expands biopharma AI and CRM offerings
Veeva Systems expands its biopharma footprint as Biogen and Regeneron adopt Vault CRM, while the company launches Veeva Falcon Safety to automate adverse event processing using AI.

Sources

01health.it · contentatscale.ai · seekingalpha.com · stocknews.com · theascent.com